Retrovirus-mediated transfer of the herpes simplex virus thymidine kinase and connexin26 genes in pancreatic cells results in variable efficiency on the bystander killing:: Implications for gene therapy

被引:29
作者
Carrió, M
Mazo, A
López-Iglesias, C
Estivill, X
Fillat, C
机构
[1] Inst Recerca Oncol, Ctr Genet Med & Mol, Barcelona 08907, Spain
[2] Univ Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain
[3] Univ Barcelona, Serv Cientificotecn, Barcelona, Spain
关键词
pancreatic cancer; gap junctions; gene therapy;
D O I
10.1002/ijc.1429
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Currently, there is no effective treatment for pancreatic cancer and prodrug-activating gene therapy with the herpes simplex virus thymidine kinase gene (HSV-tk) in combination with ganciclovir (GCV) has been suggested as a candidate approach against this disease. In the present study, we have evaluated the efficacy of the HSV-tk/GCV treatment in a panel of pancreatic tumor cells (NP-9, NP-18, NP-31) and the potentiation of the cytotoxic effect in combination with the overexpression of the connexin 26 gene (Cx26). Pancreatic cells transduced with a retrovirus containing the HSV-tk gene showed different sensitivities to GCV that seemed to be independent of HSV-tk expression levels. The extent of the bystander effect also varied among the pancreatic tumor cells and correlated with the level of gap junction intercellular communication (GJIC). Transduction of the pancreatic tumor cells with a retrovirus carrying the connexin 26 gene resulted in high levels of connexin 26 expression and in an increase In the GJIC that correlated to an extent in the bystander effect in both NP-9Cx26 and NP-18Cx26 cells. Neither an increment in GJIC nor an increase in the bystander killing was detected in NP-31Cx26. The bystander effect in NP-18 Cx26 cells was also prevented by the long term inhibitor of GJIC, 18-alpha -glycyrrhetinic acid (AGA). Together, these results demonstrate that pancreatic tumor cells are highly different as regards the susceptibility to HSV-tk/GCV treatment. Moreover, they indicate that overexpression of the Cx26 gene does not always correspond to an increase in GJIC although they clearly suggest the role of GJIC in mediating the bystander effect. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:81 / 88
页数:8
相关论文
共 33 条
  • [1] The thymidine kinase ganciclovir-mediated ''suicide'' effect is variable in different tumor cells
    Beck, C
    Cayeux, S
    Lupton, SD
    Dorken, B
    Blankenstein, T
    [J]. HUMAN GENE THERAPY, 1995, 6 (12) : 1525 - 1530
  • [2] IN-VITRO EVIDENCE THAT METABOLIC COOPERATION IS RESPONSIBLE FOR THE BYSTANDER EFFECT OBSERVED WITH HSV TK RETROVIRAL GENE-THERAPY
    BI, WL
    PARYSEK, LM
    WARNICK, R
    STAMBROOK, PJ
    [J]. HUMAN GENE THERAPY, 1993, 4 (06) : 725 - 731
  • [3] Connections with connexins: The molecular basis of direct intercellular signaling
    Bruzzone, R
    White, TW
    Paul, DL
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1996, 238 (01): : 1 - 27
  • [4] Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase gene
    Carrió, M
    Romagosa, A
    Mercadé, E
    Mazo, A
    Nadal, M
    Gómez-Foix, AM
    Fillat, C
    [J]. GENE THERAPY, 1999, 6 (04) : 547 - 553
  • [5] UNIQUE SPECTRUM OF ACTIVITY OF 9-[(1,3-DIHYDROXY-2-PROPOXY)METHYL]-GUANINE AGAINST HERPESVIRUSES INVITRO AND ITS MODE OF ACTION AGAINST HERPES-SIMPLEX VIRUS TYPE-1
    CHENG, YC
    HUANG, ES
    LIN, JC
    MAR, EC
    PAGANO, JS
    DUTSCHMAN, GE
    GRILL, SP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (09): : 2767 - 2770
  • [6] INVIVO GENE-TRANSFER WITH RETROVIRAL VECTOR PRODUCER CELLS FOR TREATMENT OF EXPERIMENTAL BRAIN-TUMORS
    CULVER, KW
    RAM, Z
    WALLBRIDGE, S
    ISHII, H
    OLDFIELD, EH
    BLAESE, RM
    [J]. SCIENCE, 1992, 256 (5063) : 1550 - 1552
  • [7] DAVIDSON JS, 1988, J PHARMACOL EXP THER, V246, P1104
  • [8] Suicide gene therapy for plasma cell tumors
    Dilber, MS
    Abedi, MR
    Bjorkstrand, B
    Christensson, B
    Gahrton, G
    Xanthopoulos, KG
    Smith, CIE
    [J]. BLOOD, 1996, 88 (06) : 2192 - 2200
  • [9] DIMAIO JM, 1994, SURGERY, V116, P205
  • [10] Connexins are expressed in primary brain tumors and enhance the bystander effect in gene therapy
    Estin, D
    Li, MW
    Spray, D
    Wu, JK
    [J]. NEUROSURGERY, 1999, 44 (02) : 361 - 368